IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,536,000 | -33.7% | 222,045 | -17.7% | 0.19% | -18.8% |
| Q2 2020 | $15,899,000 | -2.3% | 269,660 | -21.6% | 0.23% | -7.9% |
| Q1 2020 | $16,266,000 | -28.1% | 344,027 | -8.1% | 0.25% | +8.1% |
| Q4 2019 | $22,616,000 | +52.8% | 374,368 | +51.6% | 0.24% | +46.9% |
| Q3 2019 | $14,799,000 | -8.8% | 247,022 | -2.2% | 0.16% | -7.5% |
| Q2 2019 | $16,231,000 | -30.4% | 252,541 | -12.1% | 0.17% | -30.8% |
| Q1 2019 | $23,318,000 | +57.4% | 287,276 | +4.8% | 0.25% | +39.7% |
| Q4 2018 | $14,817,000 | +4.1% | 274,092 | -0.7% | 0.18% | +22.6% |
| Q3 2018 | $14,232,000 | +20.7% | 275,921 | -2.5% | 0.15% | +15.0% |
| Q2 2018 | $11,793,000 | -4.6% | 283,000 | +0.9% | 0.13% | -8.0% |
| Q1 2018 | $12,367,000 | -13.2% | 280,551 | -0.9% | 0.14% | -8.0% |
| Q4 2017 | $14,244,000 | -0.0% | 283,177 | +0.8% | 0.15% | -4.5% |
| Q3 2017 | $14,250,000 | +10.4% | 281,068 | +10.8% | 0.16% | +7.5% |
| Q2 2017 | $12,903,000 | +33.7% | 253,642 | +5.6% | 0.15% | +31.5% |
| Q1 2017 | $9,653,000 | -8.9% | 240,122 | +8.4% | 0.11% | -17.8% |
| Q4 2016 | $10,596,000 | +40.8% | 221,535 | +7.9% | 0.14% | +4.7% |
| Q3 2016 | $7,524,000 | +70.0% | 205,347 | +8.1% | 0.13% | +61.2% |
| Q2 2016 | $4,425,000 | -30.4% | 189,994 | +21.0% | 0.08% | -32.8% |
| Q1 2016 | $6,361,000 | – | 157,058 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |